CLINICAL_TRIALS
withdrawal
· 2019-12-06
Clinical Trial Update: A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planning and Execution of Surgical Revascularization in Patients With Complex Coronary Artery Disease, Based Solely on MSCT Imaging Utilizing GE Healthcare Revolution CT and HeartFlow FFRCT. [Phase 4]
Summary
A multicentre pilot Phase 4 trial evaluating surgical planning using MSCT imaging with GE Revolution CT and HeartFlow FFRCT for complex multivessel coronary art…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ECRI bv | Conditions: Multivessel Coronary Artery Disease | Phase 4 | Status: WITHDRAWN